50x32
50% by 2032. It's time the numbers caught up with the technology.
28%
of US adults with Type 1 had an A1C below 7%
19%
of US youths with Type 1 had an A1C below 7%
Diabetes technology has never been more capable. Continuous glucose monitors, automated insulin delivery, and advances in treatment have changed what's possible for people living with Type 1 diabetes.
Yet the majority still aren't reaching recommended glycemic targets. We think that's worth challenging.
Our ambition: By 2032, at least 50% of people living with Type 1 diabetes should be meeting recommended glycemic targets.
It's a big goal. One that will take better technology, broader access, more practical knowledge, and a collective effort across the diabetes community and industry.
We don't expect InStride to accomplish it alone. But we're determined to do our part.